Galizzi N, Poli A, Galli L, Muccini C, et al. Retrospective study on the outcome of two-drug regimens based on dolutegravir
plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected
patients. Int J Antimicrob Agents 2020;55:105893.
PMID: 31926287